1
|
Mir TA, Nakamura M, Sakai S, Iwanaga S, Wani SI, Alzhrani A, Arai K, Mir BA, Kazmi S, Assiri AM, Broering DC. Mammalian-specific decellularized matrices derived bioink for bioengineering of liver tissue analogues: A review. Int J Bioprint 2023; 9:714. [PMID: 37273993 PMCID: PMC10236352 DOI: 10.18063/ijb.714] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/05/2022] [Accepted: 01/18/2023] [Indexed: 06/06/2023] Open
Abstract
The absolute shortage of compatible liver donors and the growing number of potential recipients have led scientists to explore alternative approaches to providing tissue/ organ substitutes from bioengineered sources. Bioartificial regeneration of a fully functional tissue/organ replacement is highly dependent on the right combination of engineering tools, biological principles, and materiobiology horizons. Over the past two decades, remarkable achievements have been made in hepatic tissue engineering by converging various advanced interdisciplinary research approaches. Three-dimensional (3D) bioprinting has arisen as a promising state-of-the-art tool with strong potential to fabricate volumetric liver tissue/organ equivalents using viscosity- and degradation-controlled printable bioinks composed of hydrous microenvironments, and formulations containing living cells and associated supplements. Source of origin, biophysiochemical, or thermomechanical properties and crosslinking reaction kinetics are prerequisites for ideal bioink formulation and realizing the bioprinting process. In this review, we delve into the forecast of the potential future utility of bioprinting technology and the promise of tissue/organ- specific decellularized biomaterials as bioink substrates. Afterward, we outline various methods of decellularization, and the most relevant studies applying decellularized bioinks toward the bioengineering of in vitro liver models. Finally, the challenges and future prospects of decellularized material-based bioprinting in the direction of clinical regenerative medicine are presented to motivate further developments.
Collapse
Affiliation(s)
- Tanveer Ahmad Mir
- Transplant Research and Innovation Department, Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, KSA
| | - Makoto Nakamura
- Division of Biomedical System Engineering, Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan
| | - Shinji Sakai
- Division of Chemical Engineering, Department of Materials Engineering Science, Graduate School of Engineering Science, Osaka University, Toyonaka, Osaka 560-8531, Japan
| | - Shintaroh Iwanaga
- Division of Biomedical System Engineering, Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan
| | - Shadil Ibrahim Wani
- Division of Biomedical System Engineering, Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan
| | - Alaa Alzhrani
- Transplant Research and Innovation Department, Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, KSA
- Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, KSA
- College of Medicine, Alfaisal University, Riyadh 11211, KSA
| | - Kenichi Arai
- Department of Clinical Biomaterial Applied Science, Faculty of Medicine, University of Toyama, Toyama 930-0194, Japan
| | - Bilal Ahmed Mir
- Division of Intellectual Information Engineering, Graduate School of Science and Engineering, University of Toyama, Toyama 930-8555, Japan
| | - Shadab Kazmi
- Transplant Research and Innovation Department, Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, KSA
- Department of Child Health, School of Medicine, University of Missouri, Columbia, USA
| | - Abdullah M. Assiri
- Transplant Research and Innovation Department, Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, KSA
- College of Medicine, Alfaisal University, Riyadh 11211, KSA
| | - Dieter C. Broering
- Transplant Research and Innovation Department, Tissue/Organ Bioengineering & BioMEMS Laboratory, Organ Transplant Centre of Excellence, King Faisal Specialist Hospital and Research Centre, Riyadh 11211, KSA
- College of Medicine, Alfaisal University, Riyadh 11211, KSA
| |
Collapse
|